This press release is being
disseminated as required by the early warning requirements of applicable
Canadian securities laws. Paul Averback MD of 9900 Cavendish Blvd. Suite 306,
St-Laurent, Quebec, announces today that he has sold in a private...
Pharmaceutical Corporation (Nasdaq: NYMX) is pleased to announce its lead drug
candidate, NX-1207, has not shown any evidence of eliciting an immune reaction
in men treated with intraprostatic injections of the drug. Extensive...
The article on this company has not been written yet. If you're the first person to write this article, it's a sure thing that you'll be credited as a Top Contributor. For tips on getting started, check out the sample article.